aktuelle indikation opvejer risikoen for mulige, skadelige virkninger, der er forbundet med udviklingen af resistens, og finder benefit/ risk- forholdet positivt,
indication outweigh the risk for potential harmful effects related to resistance development and therefore considers the benefit-risk ratio to be positive,